Literature DB >> 34474591

Pediatric Smart Insulin Pen Use: The Next Best Thing.

Jeniece Ilkowitz1, Vanessa Wissing1, Mary Pat Gallagher1.   

Abstract

In the pediatric population, insulin pump therapy, or CSII, is often considered the gold standard for intensive diabetes management. Insulin pump technology offers families and caregivers many beneficial features including a calculator for insulin dosing and the ability to review diabetes management data to provide data-driven diabetes management. However, for those who find CSII challenging or choose to use multiple daily injections (MDI) there is an option that offers similar features called the Smart Insulin Pen (SIP). Even though SIP technology provides a safe and data-driven diabetes self-management tool for the pediatric population using MDI, there is limited pediatric specific literature. This article will describe current options, data-driven diabetes management, benefits, challenges and clinical use of SIP technology in the pediatric population.

Entities:  

Keywords:  InPen; multiple daily injections; pediatrics; smart insulin pen; type 1 diabetes

Mesh:

Substances:

Year:  2021        PMID: 34474591      PMCID: PMC9294571          DOI: 10.1177/19322968211041362

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  40 in total

1.  Subcutaneous insulin administration in infants and toddlers.

Authors:  Mudita Dhingra; Gagan Priya; Atul Dhingra; Sanjay Kalra
Journal:  J Pak Med Assoc       Date:  2018-12       Impact factor: 0.781

2.  A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy.

Authors:  Cari Berget; Laurel H Messer; Gregory P Forlenza
Journal:  Diabetes Spectr       Date:  2019-08

Review 3.  Novel Concentrated Insulin Delivery Devices: Developments for Safe and Simple Dose Conversions.

Authors:  Jeremy L Johnson; Jessica M Downes; Cassandra K Obi; Nana B Asante
Journal:  J Diabetes Sci Technol       Date:  2016-11-28

4.  Insulin Pump Use in Children with Type 1 Diabetes: Over a Decade of Disparities.

Authors:  Terri H Lipman; Steven M Willi; C W Lai; Jennifer A Smith; Oona Patil; Colin P Hawkes
Journal:  J Pediatr Nurs       Date:  2020-09-01       Impact factor: 2.145

Review 5.  Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.

Authors:  G Alexander Fleming; John R Petrie; Richard M Bergenstal; Reinhard W Holl; Anne L Peters; Lutz Heinemann
Journal:  Diabetes Care       Date:  2019-12-05       Impact factor: 19.112

6.  Optimal Use of Diabetes Devices: Clinician Perspectives on Barriers and Adherence to Device Use.

Authors:  Molly L Tanenbaum; Rebecca N Adams; Sarah J Hanes; Regan C Barley; Kellee M Miller; Shelagh A Mulvaney; Korey K Hood
Journal:  J Diabetes Sci Technol       Date:  2017-01-10

Review 7.  A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice.

Authors:  Timothy S Bailey; Jenine Y Stone
Journal:  Expert Opin Drug Deliv       Date:  2017-04-10       Impact factor: 6.648

8.  The Reference Guide to Integrate Smart Insulin Pens Into Data-Driven Diabetes Care and Education Services.

Authors:  Hope Warshaw; Diana Isaacs; Janice MacLeod
Journal:  Diabetes Educ       Date:  2020-08       Impact factor: 2.140

9.  Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis.

Authors:  Johan Jendle; Åsa Ericsson; Jens Gundgaard; Jonas Bech Møller; William J Valentine; Barnaby Hunt
Journal:  Diabetes Ther       Date:  2020-12-11       Impact factor: 2.945

10.  Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen.

Authors:  Peter Adolfsson; Niels Væver Hartvig; Anne Kaas; Jonas Bech Møller; Jarl Hellman
Journal:  Diabetes Technol Ther       Date:  2020-03-11       Impact factor: 6.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.